This is the very same corporation doing the epilepsy pharmaceutical trials for children using cannabis in Houston soon. Monsanto has already made a GMO cannabis. Monsanto poisons life, they don’t save it. Beware. ~ CC Castaneda
Read my post about GMOs.
This blog posts contain two very important articles. The first is more current and is about GMO marijuana infiltration into our dispensaries and communities already. The second goes into further detail on GMO marijuana and its this to Monsanto and GW Pharma.
Washington State Pot Scare & the Rise of GMO Marijuana
By Susanne Posel – July 7, 2014
By Susanne Posel – July 7, 2014
In the state of Washington, retail sales of recreational marijuana are expected to skyrocket as an estimated 20 more dispensaries are poised to open statewide.
Regulators, business owners and experts are decrying that marijuana “could sell out in Washington within hours of days” due to “limited harvests by licensed growers and processors, or because they failed to clear regulatory hurdles to get their product to market.”
The Washington State Liquor Control Board (LCB) has approved licensing for 80 growers out of 2,600 applicants. This is foundational causation to the pending scarcity that is being talked about by analysts.
Dominic Covra, executive director of the Center for the Study of Cannabis and Social Policy (CSCSP) explained: “Shoppers looking to get high on Tuesday could see a gram selling at $15-$30. Novelty-seekers and tourists might pay $25 or $30 per gram – roughly twice the current price at weakly regulated medical dispensaries. At those prices, heavy users will stick with neighborhood dispensaries or drug dealers.”
Cannabis edibles have not been approved for retail sales “because no processor has been cleared to operate a cannabis kitchen.”
Creating the perception of scarcity by only approving 3% applicants of marijuana growers and retailers may have ulterior motive – the pave the way for the need for genetically modified marijuana to be provided by the Bio Tech industry; specifically Monsanto.
In Colorado, the infiltration of genetically modified marijuana is being fostered by United Cannabis (UCANN) and dispensaries such as RiverRock .
Earnest Backmon, president and chairman of the board for UCANN is also the “owner and the master grower at RiverRock Colorado and is responsible for the production, processing, workflow management, JIT inventory control, security, staffing, training and recruiting.”
UCANN prides themselves on developing a “unique proprietary cannabinoid therapy program” who is currently partnered with “domestically and internationally with local businessmen, entrepreneurs, scientists, and government agencies for the purpose of promoting Best Practices in Planning, Procedures, Governance and Patient Care.”
On the board of directors for UCANN, sits John C. Hunter , consultant and special advisor to the executive board, who began his career into genetically modified organisms (GMOs) with Monsanto in 1969.
Hunter spent the next 30 years working toward boosting sales, engineering and managing the direction of Monsanto; as well as holding specialized positions as manager of various chemical divisions of Monsanto from 1989 to 2004.
During his acceptance as part of the executive team for UCANN, Hunter said: “I welcome the excitement and the challenges this nascent, albeit fast moving cannabis industry has to offer. I am thoroughly impressed with the executive team at United Cannabis. They are all reliable and notable experts in their field; passionate and dedicated to both the science and its patients. They were very helpful in addressing my initial concerns with the overall industry, and I believe the concerns of many in my generation, and have successfully illustrated the urgency and usefulness of Cannabis to public health.”
During his time with Solutia, Hunter was part of a lawsuit wherein $700 million was presented as compensation for illegal dumping of PCB and contamination by Solutia and Monsanto affecting more than 20,000 residents in Anniston, Alabama.
PCB is known to be an endocrine disruptor, a neurotoxin and carcinogenic; as well as having similar effects on the human body as Agent Orange (a chemical produced by Monsanto).
Chadwick Ruby, chief operations officer for CNAB said of Hunter: “With his decades of experience leading Fortune 500 companies, John’s insight will provide guidance to shape our company during this growth phase. He adds a unique perspective to our company that will make us a formidable player in our sector. He also understands how Cannabis has the potential to provide therapy to a wide range of people with chronic illnesses that have been underserved due to the lack of research in the field.”
A study by the Center for Tobacco Control Research and Education and Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco and the University of Helsinki pointed out how “legalizing marijuana opens the market to major corporations, including tobacco companies, which have the financial resources, product design technology to optimize puff-by-puff delivery of a psychoactive drug (nicotine), marketing muscle, and political clout to transform the marijuana market.”
The authors of the study wrote: “In the current favorable political climate for marijuana decriminalization, policymakers and public health authorities should develop and implement policies that would prevent the tobacco industry … from becoming directly involved in the burgeoning marijuana market, in a way that would replicate the smoking epidemic, which kills 480,000 Americans each year.”
Documents from 1969 show that Philip Morris was in talks with the Department of Justice (DoJ) to “secretly secure marijuana from the government for marijuana research.”
It was stated 44 years ago that Philip Morris recognized marijuana as a “possible product” the corporation wanted to explore the potentials of to market to younger audiences.
In 1970, a Philip Morris official stated: [W]e regard it as an opportunity to learn something about this controversial product, whose usage has been increasing so rapidly among the young people.”
GMO Weed? Connections Alleged Between Uruguay Marijuana Legalization, Monsanto and Soros
By Steve Elliott for Hemp News
By Steve Elliott for Hemp News
Uruguay earlier this year became the first nation in the world to legalize the cultivation, sale and possession of marijuana. Now one German researcher is alleging that billionaire speculator George Soros supported legalization in that South American country as part of a plan for corporate agribusiness giant Monsanto to move into the cannabis trade.
Engdahl alleges, on the website of the European Coalition for Just and Effective Drug Policies (ENCOD) that Monsanto is already quietly at work on a project to patent a genetically modified cannabis plant in Uruguay. Since Soros played a pivotal role in Uruguay’s legalization drive (he sits on the board of the Drug Policy Alliance), and also owns considerable Monsanto stock, Engdahl believes those two things are connected, and they point towards Monsanto involvement.
Soros’ Open Society organization distributed $34 million last year, according to Engdahl, nearly $3.5 million of which was dedicated to marijuana legalization. Open Society funded the group Regulacion Responsable (“Responsible Control”) in Uruguay; the group ran a nationwide advertising campaign for the successful legalization drive.
Engdahl alleges that Soros’ involvement in Uruguayan legalization “is part of a much larger global project,” and further than Monsanto quietly conducts research projects on marijuana and its active ingredient, THC, and how the plant can be genetically manipulated. Monsanto is, after all, the world’s largest supplier of genetically modified seeds.
Back in 1998, the British firm GW Pharmaceuticals, which markets Sativex oral spray, containing THC and CBD, signed an agreement with Dutch seed company Hortapharm (owner of the world’s largest collection of cannabis seed varieties). The agreement gives GW Pharmaceuticals the rigbht to use Hortapharm cannabis strains for their research, according to Engdahl.
The German pharmaceuticals company Bayer AG in 2003 signed an agreement with GW Bayer AG agreed to an exchange with Monsanto, where both companies agreed to share the results of their research. Monsanto thus has, according to Engdahl, “discreet access” to scientific studies on the cannabis plant and its genetic modification.
In 2009, GW announced it had succeeded in genetically altering a cannabis plant and patented a “new breed” of cannabis, Engdahl writes.
With cannabis cultivation now legally allowed in Uruguay, Engdahl says “one can easily imagine” that Monsanto sees a vast new market opening — one they could potentially control with patented GMO cannabis seeds much as they currently do with the current market in soybeans.
President Jose Mujica of Uruguay has made it clear that he wants a unique genetic code for government-approved marijuana so that legal weed can be distinguished in order to “keep the black market under control.”
GMO cannabis from Monsanto would, of course, make such control possible. Monsanto has for decades been researching genetically modified soybeans and corn.
Is Monsanto paving the way for the corporate giants of Big Pharma and Big Agriculture to replace natural strains of cannabis with their own patented GMO varieties?
Moving into marijuana could be seen as a logical next step for Monsanto. The company is reputedly investing millions of dollars into a new technology known as RNA interference (RNAi), which could be used to manipulate everything from the color of the plant to making it indigestible to insects, or resistant to certain herbicides (like the “Roundup Ready” versions of crops that Monsanto produces to withstand the herbicides the company sells).
Genetic modification through RNAi or other methods could, of course, be used to create larger, more potent marijuana plants — and plants that could be distinguished from unauthorized, “black market” marijuana through genetic testing.
Read my next installment:
GW Pharma, Linked to Monsanto, owns cancer patent & more.
GW Pharma, Linked to Monsanto, owns cancer patent & more.
Posts
No comments:
Post a Comment